AbbVie (ABBV) Insider Trading & Ownership $167.74 +1.17 (+0.70%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AbbVie (NYSE:ABBV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$130.13 M Get ABBV Insider Trade Alerts Want to know when executives and insiders are buying or selling AbbVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABBV Insider Buying and Selling by Quarter Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. AbbVie Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024John JamesU.S. Congress Member (R-MI)Sell$197.00$1,001 - $15,0008/5/2024Richard A GonzalezChairmanSell66,500$186.52$12,403,580.00 7/17/2024Richard A GonzalezChairmanSell282,845$175.00$49,497,875.00 7/2/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$165.97$1,001 - $15,0004/10/2024Michael C. BurgessU.S. Congress Member (R-TX)Sell$168.99$1,001 - $15,0004/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$177.34$1,001 - $15,0003/20/2024Nicholas DonoghoeEVPSell21,082$176.30$3,716,756.60 3/18/2024Jeffrey Ryan StewartEVPSell58,949$178.79$10,539,491.71 2/29/2024Kevin K BuckbeeSVPSell5,144$176.65$908,687.60 2/29/2024Perry C SiatisEVPSell9,891$177.39$1,754,564.49 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/29/2024Robert A MichaelCOOSell68,879$176.45$12,153,699.55 2/28/2024Richard A GonzalezCEOSell138,616$177.27$24,572,458.32 2/23/2024Perry C SiatisEVPSell13,753$177.51$2,441,295.03 2/23/2024Scott T ReentsCFOSell14,140$177.44$2,509,001.60 2/21/2024Azita Saleki-GerhardtEVPSell52,870$173.71$9,184,047.70 1/23/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$167.51$1,001 - $15,0001/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$164.77$1,001 - $15,00012/26/2023Nicholas DonoghoeEVPSell2,912$154.72$450,544.64 (Data available from 1/1/2013 forward) ABBV Insider Trading Activity - Frequently Asked Questions Who is on AbbVie's Insider Roster? The list of insiders at AbbVie includes Azita Saleki-Gerhardt, Brian L Durkin, Carrie C Strom, Elaine K Sorg, Henry O Gosebruch, Jeffrey Ryan Stewart, Kevin K Buckbee, Laura J Schumacher, Michael Severino, Nicholas Donoghoe, Perry C Siatis, Richard A Gonzalez, Robert A Michael, Roxanne S Austin, Scott T Reents, and Timothy J Richmond. Learn more on insiders at ABBV. What percentage of AbbVie stock is owned by insiders? 0.25% of AbbVie stock is owned by insiders. Learn more on ABBV's insider holdings. Which AbbVie insiders have been selling company stock? The following insiders have sold ABBV shares in the last 24 months: Azita Saleki-Gerhardt ($12,922,297.70), Carrie C Strom ($4,310,832.64), Elaine K Sorg ($6,950,048.39), Jeffrey Ryan Stewart ($18,629,366.71), Kevin K Buckbee ($908,687.60), Nicholas Donoghoe ($4,167,301.24), Perry C Siatis ($6,616,685.32), Richard A Gonzalez ($89,233,188.32), Robert A Michael ($12,153,699.55), Roxanne S Austin ($1,505,000.00), Scott T Reents ($4,949,402.96), and Timothy J Richmond ($6,924,952.80). How much insider selling is happening at AbbVie? Insiders have sold a total of 988,348 AbbVie shares in the last 24 months for a total of $169,271,463.23 sold. Which members of congress are trading AbbVie? Kathy E. Manning (D-NC) and Tommy Tuberville (R-AL) have bought shares of AbbVie in the last year totaling $24,000. John James (R-MI), Michael C. Burgess (R-TX), and Tommy Tuberville (R-AL) have sold shares totaling $32,000. AbbVie Key ExecutivesMr. Richard A. Gonzalez (Age 70)Chairman & CEO Compensation: $7.19M2 recent tradesMr. Robert A. Michael (Age 54)President & COO Compensation: $4.62MMr. Scott T. Reents (Age 56)Executive VP & CFO Compensation: $3.13MDr. Azita Saleki-Gerhardt Ph.D. (Age 61)Executive VP & COO Compensation: $3.51MMr. Jeffrey Ryan Stewart (Age 55)Executive VP & Chief Commercial Officer Compensation: $4.32MDr. Thomas J. Hudson M.D. (Age 62)Senior VP & Chief Scientific Officer of Global Research Ms. Elizabeth SheaSenior Vice President of Investor RelationsMr. Perry C. Siatis (Age 49)Executive VP, General Counsel & Secretary Mr. Sanjay NarayanSenior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic LegalMr. Timothy J. Richmond (Age 58)Executive VP & Chief Human Resources Officer Compensation: $1.12M More Insider Trading Tools from MarketBeat Related Companies Amgen Insider Ownership Gilead Sciences Insider Ownership IQVIA Insider Ownership IDEXX Laboratories Insider Ownership BioNTech Insider Ownership Illumina Insider Ownership Moderna Insider Ownership Eli Lilly and Company Insider Ownership Johnson & Johnson Insider Ownership Merck & Co., Inc. Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NYSE:ABBV) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
